Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Reviews on Recent Clinical Trials
  4. Volume 19, Issue 4
  5. Article
Volume 19, Issue 4
  • ISSN: 1574-8871
  • E-ISSN: 1876-1038

Abstract

Background

Most of the mortality after Heart Transplantation (HT) is attributed to severe cardiac allograft vasculopathy (CAV) and rejection.

Objectives

This meta-analysis aimed to investigate the effects of postoperative statin therapy on outcomes (mortality, rejection, and CAV in HT patients).

Methods

This systematic review and meta-analysis was performed on publications between 1980 and October 2023 in Web of Science, Scopus, PubMed, Cochrane, Science Direct, Google Scholar, and Embase databases. Heterogeneity was assessed using Chi-square, I2, and forest plots. Publication bias was evaluated using Begg's and Egger's tests. Analyses were performed in Stata 15 with significance at < 0.05.

Results

This meta-analysis included 17 studies comprising 4,627 participants and conducted between 1995 to 2021. Compared to non-users, the odds of mortality were lower among statin users (OR= 0.49, 95% CI: 0.32–0.75, < 0.001). The odds of CAV were also reduced with statin use (OR= 0.71, 95% CI: 0.53–0.96, = 0.027). The odds of rejection were not significantly different (OR= 0.69, 95% CI: 0.41–1.15, = 0.152). However, rejection odds were lower with statins in RCTs (OR= 0.42, 95% CI: 0.21–0.82, = 0.012) but not in case-control studies (OR= 0.87, 95% CI: 0.49-1.52, = 0.615). No publication bias was observed with Begg's test, but Egger's test showed possible bias.

Conclusion

This meta-analysis found postoperative statin use associated with lower mortality and CAV, but not overall rejection, though RCT subgroup analysis showed decreased rejection with statins. Statin therapy may improve prognosis in HT patients.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/rrct/10.2174/0115748871301446240513093612
2024-06-04
2024-11-26

  • From This Site

    /content/journals/rrct/10.2174/0115748871301446240513093612
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. TsaoC.W. AdayA.W. AlmarzooqZ.I. AlonsoA. BeatonA.Z. BittencourtM.S. BoehmeA.K. BuxtonA.E. CarsonA.P. MensahC.Y. ElkindM.S.V. EvensonK.R. Eze-NliamC. FergusonJ.F. GenerosoG. HoJ.E. KalaniR. KhanS.S. KisselaB.M. KnutsonK.L. LevineD.A. LewisT.T. LiuJ. LoopM.S. MaJ. MussolinoM.E. NavaneethanS.D. PerakA.M. PoudelR. Rezk-HannaM. RothG.A. SchroederE.B. ShahS.H. ThackerE.L. VanWagnerL.B. ViraniS.S. VoecksJ.H. WangN.Y. YaffeK. MartinS.S. Heart disease and stroke statistics—2022 update: A report from the American heart association.Circulation20221458e153e63910.1161/CIR.000000000000105235078371
     [Google Scholar]
  2. ChatzinikolaouA. TzikasS. LavdanitiM. Assessment of quality of life in patients with cardiovascular disease using the SF-36, MacNew, and EQ-5D-5L questionnaires.Cureus2021139e1798210.7759/cureus.1798234667665
     [Google Scholar]
  3. GheorgheA. GriffithsU. MurphyA. QuigleyL.H. LampteyP. PerelP. The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: A systematic review.BMC Public Health201818197510.1186/s12889‑018‑5806‑x30081871
     [Google Scholar]
  4. GolbusJ.R. AdieS. YosefM. MurthyV.L. AaronsonK.D. KonermanM.C. Statin intensity and risk for cardiovascular events after heart transplantation.ESC Heart Fail.2020752074208110.1002/ehf2.1278432578953
     [Google Scholar]
  5. MasaroneD. KittlesonM.M. FalcoL. MartucciM.L. CatapanoD. BresciaB. PetraioA. De FeoM. PacileoG. The ABC of heart transplantation—part 1: Indication, eligibility, donor selection, and surgical technique.J. Clin. Med.20231216521710.3390/jcm1216521737629260
     [Google Scholar]
  6. FuchsM. SchibilskyD. ZehW. HerzB.M. BeyersdorfF. SiepeM. Does the heart transplant have a future?Eur. J. Cardiothorac. Surg.201955S1i38i4810.1093/ejcts/ezz10731106338
     [Google Scholar]
  7. AslehR. AlnsasraH. VillavicencioM.A. DalyR.C. KushwahaS.S. Cardiac transplantation: Physiology and natural history of the transplanted heart.Compr. Physiol.20231334719476510.1002/cphy.c22000137358515
     [Google Scholar]
  8. McGwinG.Jr XieA. OwsleyC. The use of cholesterol-lowering medications and age-related macular degeneration.Ophthalmology2005112348849410.1016/j.ophtha.2004.10.02715745779
     [Google Scholar]
  9. VavvasD.G. DanielsA.B. KapsalaZ.G. GoldfarbJ.W. GanotakisE. LoewensteinJ.I. YoungL.H. GragoudasE.S. EliottD. KimI.K. TsilimbarisM.K. MillerJ.W. Regression of some high-risk features of age-related macular degeneration (AMD) in patients receiving intensive statin treatment.EBioMedicine2016519820310.1016/j.ebiom.2016.01.03327077128
     [Google Scholar]
  10. WenkeK. MeiserB. ThieryJ. ReichartB. Impact of simvastatin therapy after heart transplantation an 11-year prospective evaluation.Herz200530543143210.1007/s00059‑005‑2685‑616132246
     [Google Scholar]
  11. AnbariK. AmiriM.M. Heidari-SoureshjaniS. SherwinC.M.T. KasiriK. A systematic review and meta-analysis on the role of statins in the prevention of mortality following pancreatic cancer.Anticancer. Agents Med. Chem.202323192073208210.2174/187152062366623082409522637622694
     [Google Scholar]
  12. MemarzadehE. SoureshjaniH.S. The relationship between statin and risk of age-related macular degeneration: A systematic review and meta-analysis.J. Ophthalmol.202220221910.1155/2022/856481835586594
     [Google Scholar]
  13. HafshejaniM.A. SherwinC.M.T. SoureshjaniH.S. Do statins play any role in reducing the incidence and mortality of ovarian cancer? A systematic review and meta-analysis.J. Prev. Med. Hyg.2020613E331E33933150223
     [Google Scholar]
  14. KaziD.S. PenkoJ.M. DomingoB.K. Statins for primary prevention of cardiovascular disease.Med. Clin. North Am.2017101468969910.1016/j.mcna.2017.03.00128577620
     [Google Scholar]
  15. DarvishiM. AmiriM.M. SoureshjaniH.S. SherwinC.M. NafchiM.H. The association between statins intake and risk of post stroke pneumonia: A systematic review and meta-analysis.Curr Rev Clin Exp Pharmacol20232023
     [Google Scholar]
  16. VallakatiA. ReddyS. DunlapM.E. TaylorD.O. Impact of statin use after heart transplantation.Circ. Heart Fail.2016910e00326510.1161/CIRCHEARTFAILURE.116.00326527729391
     [Google Scholar]
  17. Szyguła-JurkiewiczB. SzczurekW. ZembalaM. Heart and lung failure, transplantology the role of statins in patients after heart transplantation.Kardiochir. Torakochirurgia Pol.201511424710.5114/kitp.2015.5056726336477
     [Google Scholar]
  18. EllimuttilT.M. HarrisonK. RollinsA.T. FeurerI.D. RegaS.A. GrayJ. MenachemJ.N. Effect of statin intensity on the progression of cardiac allograft vasculopathy.Card. Fail. Rev.20217e1510.15420/cfr.2021.0734950505
     [Google Scholar]
  19. PetersonJ. WelchV. LososM. TugwellP. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analysesOttawaOttawa Hospital Research Institute2011112
     [Google Scholar]
  20. KjaergardL.L. VillumsenJ. GluudC. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses.Ann. Intern. Med.20011351198298910.7326/0003‑4819‑135‑11‑200112040‑0001011730399
     [Google Scholar]
  21. JadadA.R. MooreR.A. CarrollD. JenkinsonC. ReynoldsD.J.M. GavaghanD.J. McQuayH.J. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Control. Clin. Trials199617111210.1016/0197‑2456(95)00134‑48721797
     [Google Scholar]
  22. MagnaniG. CarinciV. MagelliC. PotenaL. ReggianiL.B. BranziA. Role of statins in the management of dyslipidemia after cardiac transplant: Randomized controlled trial comparing the efficacy and the safety of atorvastatin with pravastatin.J. Heart Lung Transplant.200019771071510.1016/S1053‑2498(00)00128‑510930822
     [Google Scholar]
  23. MoroJ. AlmenarL. DolzM.L. IzquierdoM. AgüeroJ. LazaroS.I. OrtizV. SalvadorA. Ezetimibe in heart transplantation: Initial experience.Transplant. Proc.20073972389239210.1016/j.transproceed.2007.06.04317889199
     [Google Scholar]
  24. FildesJ.E. ShawS.M. MitsidouA. RogacevK. LeonardC.T. WilliamsS.G. YonanN. HMG-CoA reductase inhibitors deplete circulating classical and non-classical monocytes following human heart transplantation.Transpl. Immunol.200819215215710.1016/j.trim.2008.02.00218503891
     [Google Scholar]
  25. RodríguezJ.A. LeiroC.M.G. PaniaguaM.J. CuencaJ.J. HermidaL.F. JufféA. Castro-BeirasA. Rhabdomyolysis in heart transplant patients on HMG-CoA reductase inhibitors and cyclosporine.Transplant. Proc.19993162522252310.1016/S0041‑1345(99)00445‑510500698
     [Google Scholar]
  26. BaeS.S. OganesianB. GolubI. SchoemanC.C. Statin use in patients with non-HMGCR idiopathic inflammatory myopathies: A retrospective study.Clin. Cardiol.202043773274210.1002/clc.2337532432360
     [Google Scholar]
  27. SammanA. ImaiC. StraatmanL. FrolichJ. HumphriesK. IgnaszewskiA. Safety and efficacy of rosuvastatin therapy for the prevention of hyperlipidemia in adult cardiac transplant recipients.J. Heart Lung Transplant.20052481008101310.1016/j.healun.2004.07.01616102434
     [Google Scholar]
  28. Tremblay-GravelM. RacineN. de DenusS. DucharmeA. PelletierG.B. GiraldeauG. LiszkowskiM. ParentM.C. CarrierM. FortierA. WhiteM. Changes in outcomes of cardiac allograft vasculopathy over 30 years following heart transplantation.JACC Heart Fail.201751289190110.1016/j.jchf.2017.09.01429191295
     [Google Scholar]
  29. HeeneyS.A. TjugumS.L. CorkishM.E. HollisI.B. Safety and tolerability of high-intensity statin therapy in heart transplant patients receiving immunosuppression with tacrolimus.Clin. Transplant.2019331e1345410.1111/ctr.1345430485535
     [Google Scholar]
  30. AlyaydinE. PogodaC. Dell’AquilaA. MartensS. TuletaI. ReineckeH. SindermannJ.R. Cardiac allograft vasculopathy in a long-term follow-up after heart transplantation: Role of remnant cholesterol in residual inflammation.Cardiol. J.202229578279010.5603/CJ.a2022.001335373329
     [Google Scholar]
  31. NykänenA.I. HolmströmE.J. TuuminenR. KrebsR. DhaygudeK. KankainenM. JokinenJ.J. LommiJ. HelanteräI. SokolowskiR.A. SyrjäläS.O. LemströmK.B. Donor simvastatin treatment in heart transplantation: A randomized and blinded clinical trial.Circulation2019140862764010.1161/CIRCULATIONAHA.119.03993231352795
     [Google Scholar]
  32. SyrjalaS.O. HolmstromE. DhaygudeK. LommiJ. NykanenA. LemstromK. (1083) donor simvastatin treatment in heart transplantation: 5-Year results of a randomized clinical trial.J. Heart Lung Transplant.202342S4S46710.1016/j.healun.2023.02.1294
     [Google Scholar]
  33. BabaD.F. SuciuH. AvramC. DanilescoA. MoldovanD.A. RautaR.C. HumaL. SinI.A. The role of preoperative chronic statin therapy in heart transplant receipts—A retrospective single-center cohort study.Int. J. Environ. Res. Public Health2023204347110.3390/ijerph2004347136834166
     [Google Scholar]
  34. PeledY. KlempfnerR. KassifY. KoganA. MaorE. SternikL. LaveeJ. RamE. Preoperative statin therapy and heart transplantation outcomes.Ann. Thorac. Surg.202011041280128510.1016/j.athoracsur.2020.02.00532156588
     [Google Scholar]
  35. HirschE. NnaniD. PatelS. RochlaniY. VukelicS. ShinJ. ChavezP. MadanS. SimsD. JordeU. SaeedO. (450) tolerability and effectiveness of intensified statin after heart transplantation.J. Heart Lung Transplant.2023424S20810.1016/j.healun.2023.02.465
     [Google Scholar]
  36. TownsendM.L. KhouryM. KoehlD. CantorR. KirklinJ. BeasleyG. ChenC. BoyleG. ParentJ. HernandezN.B. HalnonN. (188) Statin use may not benefit pediatric heart transplant recipients: A PHTS analysis.J. Heart Lung Transplant.2023424S9310.1016/j.healun.2023.02.204
     [Google Scholar]
  37. GoehringK. KuanW. SiegA. DawsonK.L. KolodziejA.R. Effect of statin intensity in the prevention of cardiac allograft vasculopathy.J. Heart Lung Transplant.202039S4S212S21310.1016/j.healun.2020.01.839
     [Google Scholar]
  38. GolbusJ.R. AdieS. HaniganS. DorschM. RooksB. AaronsonK.D. KonermanM.C. Higher intensity statin therapy reduces clinical endpoints after heart transplantation independent of lipid levels.J. Heart Lung Transplant.201938S4S7610.1016/j.healun.2019.01.172
     [Google Scholar]
  39. KeoghA. MacdonaldP. KaanA. AboyounC. SprattP. MundyJ. Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation.J. Heart Lung Transplant.200019652953710.1016/S1053‑2498(00)00077‑210867332
     [Google Scholar]
  40. MehraM.R. UberP.A. VivekananthanK. SolisS. ScottR.L. ParkM.H. MilaniR.V. LavieC.J. Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival.J. Am. Coll. Cardiol.20024091609161410.1016/S0735‑1097(02)02340‑912427413
     [Google Scholar]
  41. KobashigawaJ.A. KatznelsonS. LaksH. JohnsonJ.A. YeatmanL. WangX.M. ChiaD. TerasakiP.I. SabadA. CogertG.A. TrosianK. HamiltonM.A. MoriguchiJ.D. KawataN. HageA. DrinkwaterD.C. StevensonL.W. Effect of pravastatin on outcomes after cardiac transplantation.N. Engl. J. Med.19953331062162710.1056/NEJM1995090733310037637722
     [Google Scholar]
  42. SeeV.Y.Jr DeNofrioD. GoldbergL. ChangG. SasseenB. KolanskyD.M. PickeringF. KaoA. LohE. WilenskyR.L. Effect of atorvastatin on postcardiac transplant increase in low-density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothelial dysfunction.Am. J. Cardiol.2003921111510.1016/S0002‑9149(03)00456‑912842237
     [Google Scholar]
  43. KobashigawaJ.A. MoriguchiJ.D. LaksH. WenerL. HageA. HamiltonM.A. CogertG. MarquezA. VassilakisM.E. PatelJ. YeatmanL. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients.J. Heart Lung Transplant.200524111736174010.1016/j.healun.2005.02.00916297773
     [Google Scholar]
  44. MahleW.T. VincentR.N. BergA.M. KanterK.R. Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation.J. Heart Lung Transplant.2005241636610.1016/j.healun.2003.10.01315653381
     [Google Scholar]
  45. StojanovicI. VrtovecB. RadovancevicB. RadovancevicR. YazdanbakhshA.P. ThomasC.D. FrazierO.H. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.J. Heart Lung Transplant.20052491235123810.1016/j.healun.2004.08.01416143239
     [Google Scholar]
  46. WuA.H. BallantyneC.M. ShortB.C. AmioneT.G. YoungJ.B. VenturaH.O. EisenH.J. RadovancevicB. RayburnB.K. LakeK.D. YancyC.W.Jr TaylorD.O. MehraM.R. KuboS.H. FishbeinD.P. ZhaoX.Q. O’BrienK.D. Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry.Am. J. Cardiol.200595336737210.1016/j.amjcard.2004.09.03515670546
     [Google Scholar]
  47. KrishnanB. VakilK.P. SankarA. DuprezD. BendittD.G. Impact of pre-operative statin use on risk of mortality and early atrial fibrillation after heart transplantation.Clin. Transplant.201630562863210.1111/ctr.1272926928633
     [Google Scholar]
  48. AslehR. BriasoulisA. PereiraN.L. BoilsonB.A. EdwardsB.S. AdigunR. MaltaisS. DalyR.C. LermanA. KushwahaS.S. Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients.ESC Heart Fail.2018561118112910.1002/ehf2.1232930019530
     [Google Scholar]
  49. GreenwayS.C. ButtsR. NaftelD.C. PruittE. KirklinJ.K. LarsenI. UrschelS. KnechtK. LawY. Statin therapy is not associated with improved outcomes after heart transplantation in children and adolescents.J. Heart Lung Transplant.201635445746510.1016/j.healun.2015.10.04026746989
     [Google Scholar]
  50. O’RourkeB. BarbirM. MitchellA.G. YacoubM.H. BannerN.R. Efficacy and safety of fluvastatin therapy for hypercholesterolemia after heart transplantation.Int. J. Cardiol.2004942-323524010.1016/j.ijcard.2003.04.00915093987
     [Google Scholar]
  51. WenkeK. MeiserB. ThieryJ. NagelD. von ScheidtW. KrobotK. SteinbeckG. SeidelD. ReichartB. Simvastatin initiated early after heart transplantation: 8-year prospective experience.Circulation20031071939710.1161/01.CIR.0000043241.32523.EE12515749
     [Google Scholar]
  52. FröhlichG.M. RufibachK. EnseleitF. WolfrumM. von BaboM. FrankM. BerliR. HermannM. HolzmeisterJ. WilhelmM. FalkV. NollG. LüscherT.F. RuschitzkaF. Statins and the risk of cancer after heart transplantation.Circulation2012126444044710.1161/CIRCULATIONAHA.111.08105922761452
     [Google Scholar]
  53. GrigioniF. CarigiS. PotenaL. FabbriF. RussoA. MusuracaA.C. CoccoloF. MagnaniG. OrtolaniP. LeoneO. ArpesellaG. MagelliC. BranziA. Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice.Transplant. Proc.20063851507151010.1016/j.transproceed.2006.02.07116797344
     [Google Scholar]
  54. LuoC.M. ChouN.K. ChiN.H. ChenY.S. YuH.Y. ChangC.H. WangC.H. TsaoC.I. WangS.S. The effect of statins on cardiac allograft survival.Transplant. Proc.201446392092410.1016/j.transproceed.2013.11.01624767381
     [Google Scholar]
  55. MehraM.R. RavalN.Y. Metaanalysis of statins and survival in de novo cardiac transplantation.Transplant. Proc.20043651539154110.1016/j.transproceed.2004.05.03615251380
     [Google Scholar]
  56. BecchettiC. DirchwolfM. SchroppJ. MaginiG. MüllhauptB. ImmerF. DufourJ.F. BanzV. BerzigottiA. BoschJ. Use of statins after liver transplantation is associated with improved survival: Results of a nationwide study.Aliment. Pharmacol. Ther.20225671194120410.1111/apt.1719235979872
     [Google Scholar]
  57. BrugtsJ.J. YetginT. HoeksS.E. GottoA.M. ShepherdJ. WestendorpR.G.J. de CraenA.J.M. KnoppR.H. NakamuraH. RidkerP. van DomburgR. DeckersJ.W. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: Meta-analysis of randomised controlled trials.BMJ2009338jun30 1b237610.1136/bmj.b237619567909
     [Google Scholar]
  58. RamkumarS. RaghunathA. RaghunathS. Statin therapy: Review of safety and potential side effects.CMR. Cardiac MRI. SGRE.201632663163927899849
     [Google Scholar]
/content/journals/rrct/10.2174/0115748871301446240513093612
Loading
A Systematic Review and Meta-Analysis of the Effects of Statin Therapy on Heart Transplantation
Rev. Recent Clin. Trials 19, 256 (2024); https://doi.org/10.2174/0115748871301446240513093612
/content/journals/rrct/10.2174/0115748871301446240513093612
/content/journals/rrct/10.2174/0115748871301446240513093612
Loading

Data & Media loading...

Supplements

file format download Download

  • Article Type:     Research Article
Keyword(s): Cardiovascular diseases (CVD); CAV; heart transplantation; Postoperative; RCT subgroup; statin therapy

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test